Synapse-Related Serum and P300 Biomarkers Predict the Occurrence of Mild Cognitive Impairment in Depression

References

• Price RB, Duman R. Neuroplasticity in cognitive and psychological mechanisms of depression: an integrative model. Mol Psychiatry. 2020;25(3):530–543. doi:10.1038/s41380-019-0615-x
   Web of Science ®Google Scholar
• Matcham F, Simblett SK, Leightley D, et al. The association between persistent cognitive difficulties and depression and functional outcomes in people with major depressive disorder. Psychol Med. 2023;53(13):6334–6344. doi:10.1017/S0033291722003671
   Web of Science ®Google Scholar
• Porter RJ, Douglas KM. Cognitive impairment in people remitted from major depression. Lancet Psychiatry. 2019;6(10):799–800. doi:10.1016/S2215-0366(19)30278-0
   Web of Science ®Google Scholar
• Semkovska M, Quinlivan L, O’Grady T, et al. Cognitive function following a major depressive episode: a systematic review and meta-analysis. Lancet Psychiatry. 2019;6(10):851–861. doi:10.1016/S2215-0366(19)30291-3
   PubMed Web of Science ®Google Scholar
• Kriesche D, Woll CFJ, Tschentscher N, Engel RR, Karch S. Neurocognitive deficits in depression: a systematic review of cognitive impairment in the acute and remitted state. Eur Arch Psychiatry Clin Neurosci. 2023;273(5):1105–1128. doi:10.1007/s00406-022-01479-5
   Web of Science ®Google Scholar
• Wang G, Si TM, Li L, et al. Cognitive symptoms in major depressive disorder: associations with clinical and functional outcomes in a 6-month, non-interventional, prospective study in China. Neuropsychiatr Dis Treat. 2019;15:1723–1736. doi:10.2147/NDT.S195505
   PubMed Web of Science ®Google Scholar
• Kaser M, Zaman R, Sahakian BJ. Cognition as a treatment target in depression. Psychol Med. 2017;47(6):987–989. doi:10.1017/S0033291716003123
   PubMed Web of Science ®Google Scholar
• Sociali A, Borgi M, Pettorruso M, et al. What role for cognitive remediation in the treatment of depressive symptoms? A superiority and noninferiority meta-analysis for clinicians. Depress Anxiety. 2022;39(7):586–606. doi:10.1002/da.23263
   PubMed Web of Science ®Google Scholar
• Mecca AP, O’Dell RS, Sharp ES, et al. Synaptic density and cognitive performance in Alzheimer’s disease: a PET imaging study with [11 C]UCB-J. Alzheimers Dement. 2022;18(12):2527–2536. doi:10.1002/alz.12582
   Web of Science ®Google Scholar
• Xu L, Zhou Y, Hu L, et al. Deficits in N-Methyl-D-Aspartate receptor function and synaptic plasticity in hippocampal CA1 in APP/PS1 mouse model of Alzheimer’s disease. Front Aging Neurosci. 2021;13:772980. doi:10.3389/fnagi.2021.772980
   Web of Science ®Google Scholar
• Wang CS, Kavalali ET, Monteggia LM. BDNF signaling in context: from synaptic regulation to psychiatric disorders. Cell. 2022;185(1):62–76. doi:10.1016/j.cell.2021.12.003
   Web of Science ®Google Scholar
• Gupta S, M-Redmond T, Meng F, et al. Fibroblast growth factor 2 regulates activity and gene expression of human post-mitotic excitatory neurons. J Neurochem. 2018;145(3):188–203. doi:10.1111/jnc.14255
   Web of Science ®Google Scholar
• Terauchi A, Timmons KM, Kikuma K, Pechmann Y, Kneussel M, Umemori H. Selective synaptic targeting of the excitatory and inhibitory presynaptic organizers FGF22 and FGF7. J Cell Sci. 2015;128(2):281–292. doi:10.1242/jcs.158337
   Web of Science ®Google Scholar
• Babiloni C, Blinowska K, Bonanni L, et al. What electrophysiology tells us about Alzheimer’s disease: a window into the synchronization and connectivity of brain neurons. Neurobiol Aging. 2020;85:58–73. doi:10.1016/j.neurobiolaging.2019.09.008
   PubMed Web of Science ®Google Scholar
• Tarawneh HY, Mulders WHAM, Sohrabi HR, Martins RN, Jayakody DMP. Investigating auditory electrophysiological measures of participants with mild cognitive impairment and alzheimer’s disease: a systematic review and meta-analysis of event-related potential studies. J Alzheimers Dis. 2021;84(1):419–448. doi:10.3233/JAD-210556
   PubMed Web of Science ®Google Scholar
• Fitzgerald K, Todd J. Making sense of mismatch negativity. Front Psychiatry. 2020;11:468. doi:10.3389/fpsyt.2020.00468
   Web of Science ®Google Scholar
• Deardorff WJ, Lee SJ. Mild cognitive impairment as a clinical and research outcome: ready for prime time? J Am Geriatr Soc. 2022;70(5):1361–1364. doi:10.1111/jgs.17744
   Web of Science ®Google Scholar
• Albert MS, DeKosky ST, Dickson D, et al. The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 2011;7(3):270–279. doi:10.1016/j.jalz.2011.03.008
   PubMed Web of Science ®Google Scholar
• Czerwińska A, Pawłowski T. Cognitive dysfunctions in depression - significance, description and treatment prospects. Psychiatr Pol. 2020;54(3):453–466. doi:10.12740/PP/OnlineFirst/105415
   Web of Science ®Google Scholar
• Shilyansky C, Williams LM, Gyurak A, Harris A, Usherwood T, Etkin A. Effect of antidepressant treatment on cognitive impairments associated with depression: a randomised longitudinal study. Lancet Psychiatry. 2016;3(5):425–435. doi:10.1016/S2215-0366(16)00012-2
   PubMed Web of Science ®Google Scholar
• Numakawa T, Kajihara R. Neurotrophins and other growth factors in the pathogenesis of Alzheimer’s disease. Life. 2023;13(3):647. doi:10.3390/life13030647
   Google Scholar
• Terauchi A, Johnson-Venkatesh EM, Bullock B, Lehtinen MK, Umemori H. Retrograde fibroblast growth factor 22 (FGF22) signaling regulates insulin-like growth factor 2 (IGF2) expression for activity-dependent synapse stabilization in the mammalian brain. Elife. 2016;5:e12151. doi:10.7554/eLife.12151
   Web of Science ®Google Scholar
• Terauchi A, Johnson-Venkatesh EM, Toth AB, Javed D, Sutton MA, Umemori H. Distinct FGFs promote differentiation of excitatory and inhibitory synapses. Nature. 2010;465(7299):783–787. doi:10.1038/nature09041
   Web of Science ®Google Scholar
• Jiang S, Qu C, Wang F, et al. Using event-related potential P300 as an electrophysiological marker for differential diagnosis and to predict the progression of mild cognitive impairment: a meta-analysis. Neurol Sci. 2015;36(7):1105–1112. doi:10.1007/s10072-015-2099-z
   Web of Science ®Google Scholar